The subject (subject 1) that needed arginine or GLP-1 on top of hyperglycemia during the three-phase hyperglycemic clamp to unmask detectable C-peptide, showed detectable C-peptide only after the arginine bolus at the end of the MMTT. The gene discussed is GCG; the disease is Hyperglycemia.